SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-303215
Filing Date
2014-08-08
Accepted
2014-08-08 16:32:18
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d750121d10q.htm 10-Q 548534
2 EX-31.1 d750121dex311.htm EX-31.1 9584
3 EX-31.2 d750121dex312.htm EX-31.2 9974
4 EX-32.1 d750121dex321.htm EX-32.1 4586
  Complete submission text file 0001193125-14-303215.txt   5425976

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aria-20140630.xml EX-101.INS 687275
6 XBRL TAXONOMY EXTENSION SCHEMA aria-20140630.xsd EX-101.SCH 57135
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aria-20140630_cal.xml EX-101.CAL 76563
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aria-20140630_def.xml EX-101.DEF 335613
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aria-20140630_lab.xml EX-101.LAB 444278
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aria-20140630_pre.xml EX-101.PRE 400831
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36172 | Film No.: 141027897
SIC: 2836 Biological Products, (No Diagnostic Substances)